Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: A meta-analytic investigation

Schizophrenia Bulletin

Volumn 38, Issue 2, 2012, Pages 304-315

  Tolman, Arielle W ^a   Kurtz, Matthew M ^a  

^a WESLEYAN UNIVERSITY   (United States)

Author keywords

cognition; outcome; psychotic illness

Indexed keywords

ARTICLE; COGNITION; HUMAN; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUALITY OF LIFE; SCHIZOPHRENIA;

COGNITION DISORDERS; HUMANS; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84857568018     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbq077     Document Type: Article

References (60)

1. Eack SM, Newhill CE. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull. 2007;33:1225-1237.
2. Awad AG, Voruganti LP. Intervention research in psychosis: issues related to the assessment of quality of life. Schizophr Bull. 2000;26:557-564.
3. Lehman AF. Measures of quality of life among persons with severe and persistent mental disorders. Soc Psychiatry Psychiatr Epidemiol. 1996;31 (2):78-88.
4. Gold J, Harvey PD. Cognitive deficits in schizophrenia. The Psychiatr Clin North Am. 1993;16:295-312.
5. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12:426-445.
6. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996;153:321-330.
7. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff "? Schizophr Bull. 2000;26 (1):119-136.
8. Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004;72 (1):41-51.
9. Elvevag B, Goldberg TE. Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol. 2000;14 (1):1-21.
10. Addington J, Addington D. Social and cognitive functioning in psychosis. Schizophr Res. 2008;99(1-3):176-181.
11. Lysaker P, Davis L. Social function in schizophrenia and schizoaffective disorder: associations with personality, symptoms and neurocognition. Health Qual Life Outcomes. 2004;2 (1):15.
12. Corrigan PW, Buican B. The construct validity of subjective quality of life for the severely mentally ill. J Nerv Ment Dis. 1995;183:281-285.
13. Proteau A, Verdoux H, Briand C, et al. Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program. Schizophr Res. 2005;77:343-353.
14. Heslegrave RJ, Awad AG, Voruganti LN. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. J Psychiatry Neurosci. 1997;22:235-243.
15. Hofer A, Baumgartner S, Bodner T, et al. Patient outcomes in schizophrenia II: the impact of cognition. Eur Psychiatry. 2005;20:395-402.
16. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA. 1994;272:619-626.
17. Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plann. 1988;11:51-62.
18. Brissos S, Dias VV, Carita AI, Martinez-Arán A. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates. Psychiatry Res. 2008;160 (1):55-62.
19. Chino B, Nemoto T, Fujii C, Mizuno M. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia. Psychiatry Clin Neurosci. 2009;63:521-528.
20. Bain GH, Lemmon H, Teunisse S, et al. Quality of Life in healthy old age: relationships with childhood IQ, minor psychological symptoms and optimism. Soc Psychiatry Psychiatr Epidemiol. 2003;38:632-636.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-III. Washington, DC: American Psychiatric Press. 1987.
22. Addington J, Addington D. Neurocognitive and social functioning in schizophrenia. Schizophr Bull. 1999;25:173-182.
23. Dickinson D, Coursey RD. Independence and overlap among neurocognitive correlates of community functioning in schizophrenia. Schizophr Res. 2002;56(1-2):161-170.
24. Fiszdon JM, Choi J, Goulet J, Bell MD. Temporal relationship between change in cognition and change in functioning in schizophrenia. Schizophr Res. 2008;105(1-3):105-113.
25. Lipkovich I, Deberdt W, Csernansky JG, et al. Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24-months of antipsychotic drug therapy. BMC Psychiatry. 2009;9:44.
26. Matsui M, Sumiyoshi T, Arai H, Higuchi Y, Kurachi M. Cognitive functioning related to quality of life in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:280-287.
27. Narvaez JM, Twamley EW, McKibbin CL, Heaton RK, Patterson TL. Subjective and objective quality of life in schizophrenia. Schizophr Res. 2008;98:201-208.
28. Savilla K, Kettler L, Galletly C. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Aust N Z J Psychiatry. 2008;42:496-504.
29. Alptekin K, Akvardar Y, Akdede BB, et al. Is quality of life associated with cognitive impairment in schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:239-244.
30. Brekke JS, Kohrt B, Green MF. Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia. Schizophr Bull. 2001;27:697-708.
31. Dickerson F, Ringel NB, Parente F. Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates. Acta Psychiatr Scand. 1998;98 (2):124-127.
32. Herman M. Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients. Int J Ment Health Nurs. 2004;13:282-291.
33. Smith TE, Hull JW, Goodman M, et al. The relative influence of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis. 1999;187 (2):102-108.
34. Heinrichs DW, Hanlon TE, Carpenter WT. The Quality of Life Scale: an instrument for assessing the schizophrenic deficit syndrome. Schizophr Bull. 1984;10:388-396.
35. Strauss J, Carpenter WT. Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors. Arch Gen Psychiatry. 1977;34 (2):159-163.
36. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19:787-805.
37. Voruganti LN, Heslegrave RJ, Awad AG. Neurocognitive correlates of positive and negative syndromes in schizophrenia. Can J Psychiatry. 1997;43:854-855.
38. Sota TL, Heinrichs RW. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics. Compr Psychiatry. 2004;45:415-421.
39. WHO Group. The World Health Organization WHOQOLBREF quality of life assessment. Psychol Med. 1998;28:551-558.
40. Stein LI, Test MA. Alternatives to mental hospital treatment: I. Conceptual model treatment program and clinical evaluation. Arch Gen Psychiatry. 1980;37:392-397.
41. Oliver JP, Huxley PJ, Priebe S, Kaiser W. Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile. Soc Psychiatry Psychiatr Epidemiol. 1997;32 (2):76-83.
42. Johnson BT. DSTAT: Software for Meta-Analytic Reviews of Research Literature [computer program]. Hillsdale, NJ: Erlbaum; 1993.
43. Peterson RA, Brown SP. On the use of beta coefficients in meta-analysis. J Appl Psychol. 2005;90 (1):175-181.
44. Lipsey MW, Wilson DB. The way in which intervention studies have "personality" and why it is important to metaanalysis. Eval Health Prof. 2001;24:236-254.
45. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York, NY: Academic Press; 1977.
46. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. New York, NY: Academic Press; 1985.
47. Orwin RG. A fail-safe N for meta-analysis. J Educ Stat. 1983;8 (2):157-159.
48. Kay SR, Fizszbein A, Opler LA. The positive and negative syndrome scale for schizophrenia. Schizophr Bull. 1987;13:261-276.
49. Spitzer R, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for the DSM-III-R. Washington, DC: American Psychiatric Press; 1990.
50. Rosenthal R. Meta-Analytic Procedures for Social Research. London, UK: Sage; 1986.
51. Penn DL, Sanna LJ, Roberts DL. Social cognition in schizophrenia: an overview. Schizophr Bull. 2008;34:408-411.
52. Bowie CR, Leung WW, Reichenberg AA, et al. Predicting schizophrenia patients' real world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry. 2008;63:505-511.
53. Addington J, Saeedi H, Addington D. Facial affect recognition: a mediator between cognitive and social functioning in psychosis? Schizophr Res. 2006;85(1-3):142-150.
54. Skantze K, Malm U, Dencker SJ, May PR, Corrigan P. Comparison of quality of life with standard of living in schizophrenic out-patients. Br J Psychiatry. 1992;161:797-801.
55. Warner R, de Girolamo G, Belelli G, Bologna C, Fioritti A, Rosini G. The quality of life of people with schizophrenia in Boulder, Colorado, and Bologna, Italy. Schizophr Bull. 1998;24:559-568.
56. Karow A, Pajonk FG. Insight and quality of life in schizophrenia: recent findings and treatment implications. Curr Opin Psychiatry. 2006;19:637-641.
57. Bowie CR, Twamley EW, Anderson H, Halpern B, Patterson TL, Harvey PD. Self-assessment of functional status in schizophrenia. J Psychiatr Res. 2007;41:1012-1018.
58. Subotnik KL, Nuechterlein KH, Irzhevsky V, Kitchen CM, Woo SM, Mintz J. Is unawareness of psychotic disorder a neurocognitive or psychological defensiveness problem? Schizophr Res. 2005;75(2-3):147-157.
59. Marder S. Initiatives to promote the discovery of drugs to improve cognition in severe mental illness. J Clin Psychiatry. 2006;67(7):e03.
60. McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry. 2007;164:437-441.